Cerebellar Atrophy in Systemic Sclerosis

al Arfaj H.F. , Naddaf H.O. Cerebellar atrophy in systemic lupus erythematosus. Lupus 1995; 4: 412–14

Singh R.R. , Prasad K. , Kumar A. , Misra A. , Padmakumar K. , Malaviya A.N. Cerebellar ataxia in systemic lupus erythematosus: three case reports. Ann Rheum Dis 1988; 47: 954–6

Ho K.T. , Reveille J.D. The clinical relevance of autoantibodies in scleroderma. Arthritis Res Ther 2003; 5: 80–93

Solomon D.H. , Kavanaugh A.J. , Schur P.H. Evidence-based guidelines for the use of immunologic tests: antinuclear antibody testing. Arthritis Rheum 2002; 47: 434–44

Peene I. , Meheus L. , Veys E.M. , De Keyser F. Diagnostic associations in a large and consecutively identified population positive for anti-SSA and/or anti-SSB: the range of associated diseases differs according to the detailed serotype. Ann Rheum Dis 2002; 61: 1090–4

Averbuch-Heller L. , Steiner I. , Abramsky O. Neurologic manifestations of progressive systemic sclerosis. Arch Neurol 1992; 49: 1292–5

Cutolo M. , Nobili F. , Suli A. . Evidence of cerebral hypoperfusion in scleroderma patients. Rheumatology 2000; 39: 1366–73

Tomita M. , Holman B.J. , Williams L.S. , Pang K.C. , Santoro T.J. Cerebellar dysfunction is associated with overexpression of proinflammatory cytokine genes in lupus. J Neurosci Res 2001; 64: 26–33